Coya Therapeutics Announces the First Cohort of Patients in the ALSTARS Trial Have Begun the Blinded Active-Treatment Extension Phase

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/2/2026

1. SPY
2. TSLA
3. META
4. STZ
5. GOOGL
6. FDS
7. NVDA
8. FUTU
9. HOOD
10. VEON

Go back to Coya Therapeutics Announces the First Cohort of Patients in the ALSTARS Trial Have Begun the Blinded Active-Treatment Extension Phase
(NASDAQ: COYA) Delayed: 5.78 +0.12 (2.12%)
Previous Close $5.66    52 Week High $ 
Open $5.75    52 Week Low $ 
Day High $6.10    P/E N/A 
Day Low $5.65    EPS $ 
Volume 34,464